Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Two High Throughput Screen Assays for Measurement of TNF-α in THP-1 Cells.

Leister KP, Huang R, Goodwin BL, Chen A, Austin CP, Xia M.

Curr Chem Genomics. 2011;5:21-9. doi: 10.2174/1875397301105010021. Epub 2011 May 10.

2.

A high-throughput screening assay for determining cellular levels of total tau protein.

Dehdashti SJ, Zheng W, Gever JR, Wilhelm R, Nguyen DT, Sittampalam G, McKew JC, Austin CP, Prusiner SB.

Curr Alzheimer Res. 2013 Sep;10(7):679-87.

3.

A one-day, dispense-only IP-One HTRF assay for high-throughput screening of Galphaq protein-coupled receptors: towards cells as reagents.

Bergsdorf C, Kropp-Goerkis C, Kaehler I, Ketscher L, Boemer U, Parczyk K, Bader B.

Assay Drug Dev Technol. 2008 Feb;6(1):39-53. doi: 10.1089/adt.2007.108.

PMID:
18315499
4.

HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications.

Degorce F, Card A, Soh S, Trinquet E, Knapik GP, Xie B.

Curr Chem Genomics. 2009 May 28;3:22-32. doi: 10.2174/1875397300903010022.

5.

The use of AlphaScreen technology in HTS: current status.

Eglen RM, Reisine T, Roby P, Rouleau N, Illy C, Bossé R, Bielefeld M.

Curr Chem Genomics. 2008 Feb 25;1:2-10. doi: 10.2174/1875397300801010002.

6.

A homogeneous time-resolved fluorescence-based high-throughput screening system for discovery of inhibitors of IKKbeta-NEMO interaction.

Gotoh Y, Nagata H, Kase H, Shimonishi M, Ido M.

Anal Biochem. 2010 Oct 1;405(1):19-27. doi: 10.1016/j.ab.2010.05.028. Epub 2010 Jun 1.

PMID:
20522330
7.

Current status of HTRF(®) technology in kinase assays.

Jia Y.

Expert Opin Drug Discov. 2008 Dec;3(12):1461-74. doi: 10.1517/17460440802518171.

PMID:
23506109
8.

Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence.

Park YW, Cummings RT, Wu L, Zheng S, Cameron PM, Woods A, Zaller DM, Marcy AI, Hermes JD.

Anal Biochem. 1999 Apr 10;269(1):94-104.

PMID:
10094779
9.

A novel cell-based duplex high-throughput screening assay combining fluorescent Ca(2+) measurement with homogeneous time-resolved fluorescence technology.

Kiss L, Cselenyák A, Varga Á, Visegrády A.

Anal Biochem. 2016 Aug 15;507:33-9. doi: 10.1016/j.ab.2016.05.009. Epub 2016 May 24.

PMID:
27235172
10.

[HTRF-based high-throughput PGE2 release prohibition model and application in discovering traditional Chinese medicine active ingredients].

Bai ZR, Fei HQ, Li N, Cao L, Zhang CF, Wang TJ, Ding G, Wang ZZ, Xiao W.

Zhongguo Zhong Yao Za Zhi. 2016 Feb;41(3):509-513. doi: 10.4268/cjcmm20160325. Chinese.

PMID:
28868872
11.

Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).

Schröter T, Minond D, Weiser A, Dao C, Habel J, Spicer T, Chase P, Baillargeon P, Scampavia L, Schürer S, Chung C, Mader C, Southern M, Tsinoremas N, LoGrasso P, Hodder P.

J Biomol Screen. 2008 Jan;13(1):17-28. doi: 10.1177/1087057107310806.

PMID:
18227223
12.

Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization.

Jia Y, Quinn CM, Clabbers A, Talanian R, Xu Y, Wishart N, Allen H.

Anal Biochem. 2006 Mar 15;350(2):268-76. Epub 2005 Nov 30.

PMID:
16356459
13.

A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).

Vainshtein I, Silveria S, Kaul P, Rouhani R, Eglen RM, Wang J.

J Biomol Screen. 2002 Dec;7(6):507-14.

PMID:
14599348
14.

Targeting cytokines: production and characterization of anti-TNF-α scFvs by phage display technology.

Abdolalizadeh J, Nouri M, Zolbanin JM, Barzegari A, Baradaran B, Barar J, Coukos G, Omidi Y.

Curr Pharm Des. 2013;19(15):2839-47.

PMID:
23432628
15.

Miniaturization and automation of an ubiquitin ligase cascade enzyme-linked immunosorbent assay in 1,536-well format.

Cassaday J, Shah T, Murray J, O'Donnell GT, Kornienko O, Strulovici B, Ferrer M, Zuck P.

Assay Drug Dev Technol. 2007 Aug;5(4):493-500.

PMID:
17767417
16.

Identification and Characterization of a New Series of Ghrelin O-Acyl Transferase Inhibitors.

Yoneyama-Hirozane M, Deguchi K, Hirakawa T, Ishii T, Odani T, Matsui J, Nakano Y, Imahashi K, Takakura N, Chisaki I, Takekawa S, Sakamoto J.

SLAS Discov. 2017 Aug 1:2472555217727097. doi: 10.1177/2472555217727097. [Epub ahead of print]

PMID:
28846466
17.

A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists.

Golla R, Seethala R.

J Biomol Screen. 2002 Dec;7(6):515-25.

PMID:
14599349
18.

Development of multiple cell-based assays for the detection of histone H3 Lys27 trimethylation (H3K27me3).

Qian J, Lu L, Wu J, Ma H.

Assay Drug Dev Technol. 2013 Sep;11(7):449-56. doi: 10.1089/adt.2013.515. Epub 2013 Aug 30.

19.

A homogeneous HTRF assay for the identification of inhibitors of the TWEAK-Fn14 protein interaction.

Benicchi T, Iozzi S, Svahn A, Axelsson H, Mori E, Bernocco S, Cappelli F, Caramelli C, Fanti P, Genesio E, Maccari L, Markova N, Micco I, Porcari V, Schultz J, Fecke W.

J Biomol Screen. 2012 Aug;17(7):933-45. doi: 10.1177/1087057112447873. Epub 2012 May 29.

PMID:
22644269
20.

Conversion of a capture ELISA to a Luminex xMAP assay using a multiplex antibody screening method.

Baker HN, Murphy R, Lopez E, Garcia C.

J Vis Exp. 2012 Jul 6;(65). pii: 4084. doi: 10.3791/4084.

Supplemental Content

Support Center